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This diploma thesis display posibility of tumor treatment by antibodies, their conjugates 
and antibody fragments. Antibody therapy uses natural antibody binding of tumor cell 
or other abnormal cell. Antibodies bind only cells with cellular biomarkers which are 
present on target cells. Binding initiate disposal process of damaged cell. Genetic 
engineering helps to create different antibodies and their conjugates with different 
qualities, especially various affinity to specific structures they recognise. Unconjugated 
antibodies are chimerical, humanized, pure human or pure murine. Conjugated 
antibodies are represented by imunoconjugates, conjugates with cytostatics, with 
enzymes, with phytogenic or animal toxines. Developement of antibodies has totally 
new phenomenon – creating of antibody fragments. These elements are products of 
genetic engineering and their utilization has a great future. This work summarizes the 
latest knowledge about using monoclonal antibodies and immuoconjugates in 
theanticancer therapy. 
 
  
